Based on the gene expression profiling, breast tumors were subclassified into four groups by Perou et al., which include basal-like, ERBB2-positive (HER2-positive), normal-breast-like, and luminal epithelial/estrogen receptor (ER) positive (Perou et al. 2000). This evidence concerns the gene ESR1 and breast neoplasm.